Richard Laing, MBChB, MSc (CHDC) MD
Boston University School of Public Health
Dept of Global Health

MD, University of Zimbabwe
MBChB, University of Zimbabwe
MSc, University of London

Originally trained as a medical doctor, worked in the Ministry of Health in Zimbabwe for 18 years at all levels, during which time undertook postgraduate Masters and Doctoral studies in England on Community Health for Developing countries and on Comparative Health Systems & Policy Analysis.

Worked for six years as a Boston based consultant establishing the International Network for the Rational Use of Drugs (INRUD) consulting, teaching and writing.
Moved to Boston University School of Public Health teaching, researching and consulting mostly on Pharmaceutical Policy Issues.

Worked at WHO (2003-2013), Geneva on Pharmaceutical Policy Issues focusing on Pharmaceutical Innovation, Access and Pricing and integration of National Medicine Policies into National Health Policies.

Since 2014 working at Boston University School of Public Health as a Professor of Global Health teaching primarily on the Pharmaceuticals track and as an Extraordinary Professor at University of Western Cape School of Public Health working on developing materials, short course and distance learning courses related to pharmaceutical management.

Undertaking research on Access to Insulin and evaluation of industry initiated activities related to access to medicines for Non Communicable Diseases.

2009 Utrecht University: Honorary degree Doctoris Honoris Causae
1985-1986 Beit Trust: Beit Fellowship
1984-1985 Commonwealth Secretariat: Commonwealth Fellowship

04/01/2017 - 03/31/2019 (PI)
International Federation of Pharmaceutical Manufacturers Association

Novartis Access Initiative Task Order 4
11/01/2017 - 12/31/2018 (PI)
Sandoz International GmbH

Novartis Access Initiative Task Order 3
10/01/2016 - 04/30/2018 (PI)
Sandoz International GmbH

Novartis Access Initiative Task Order 2
04/29/2016 - 02/28/2018 (PI)
Sandoz International GmbH

08/01/2016 - 12/30/2017 (PI)
International Federation of Pharmaceutical Manufacturers Association

Novartis Access Initiative Task Order 1
12/01/2015 - 04/30/2017 (PI)
Sandoz International GmbH

Yr Title Project-Sub Proj Pubs
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Mehrtash H, Laing R, Wirtz VJ. Comparative analysis of essential medicines for cardiovascular diseases in countries of the WHO Eastern Mediterranean Region. East Mediterr Health J. 2018 Jul 17; 24(5):427-434.View Related Profiles. PMID: 30043961.
  2. Rockers PC, Laing RO, Wirtz VJ. Equity in access to non-communicable disease medicines: a cross-sectional study in Kenya. BMJ Glob Health. 2018; 3(3):e000828.View Related Profiles. PMID: 29989082.
  3. Wirtz VJ, Turpin K, Laing RO, Mukiira CK, Rockers PC. Access to medicines for asthma, diabetes and hypertension in eight counties of Kenya. Trop Med Int Health. 2018 May 29.View Related Profiles. PMID: 29808960; DOI: 10.1111/tmi.13081;.
  4. Barakat D, Rockers PC, Vian T, Onyango MA, Laing RO, Wirtz VJ. Access to asthma medicines at the household level in eight counties of Kenya. Int J Tuberc Lung Dis. 2018 May 01; 22(5):585-590.View Related Profiles. PMID: 29663966.
  5. Magadzire BP, Marchal B, Mathys T, Laing RO, Ward K. Analyzing implementation dynamics using theory-driven evaluation principles: lessons learnt from a South African centralized chronic dispensing model. BMC Health Serv Res. 2017 Dec 04; 17(Suppl 2):724. PMID: 29219098.
  6. Rockers PC, Wirtz VJ, Umeh CA, Swamy PM, Laing RO. Industry-Led Access-To-Medicines Initiatives In Low- And Middle-Income Countries: Strategies And Evidence. Health Aff (Millwood). 2017 Apr 01; 36(4):706-713.View Related Profiles. PMID: 28373337; DOI: 10.1377/hlthaff.2016.1213;.
  7. Ewen M, Zweekhorst M, Regeer B, Laing R. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases. PLoS One. 2017; 12(2):e0171284. PMID: 28170413; DOI: 10.1371/journal.pone.0171284;.
  8. Ewen M, Kaplan W, Gedif T, Justin-Temu M, Vialle-Valentin C, Mirza Z, Regeer B, Zweekhorst M, Laing R. Prices and availability of locally produced and imported medicines in Ethiopia and Tanzania. J Pharm Policy Pract. 2017; 10:7.View Related Profiles. PMID: 28116107.
  9. Rockers PC, Wirtz VJ, Vian T, Onyango MA, Ashigbie PG, Laing R. Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya. BMJ Open. 2016 Nov 25; 6(11):e013386.View Related Profiles. PMID: 27888177; DOI: 10.1136/bmjopen-2016-013386;.
  10. Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Response by Wirtz et al to Letter Regarding Article, "Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries". Circulation. 2016 10 04; 134(14):e305-e306.View Related Profiles. PMID: 27698055.
Showing 10 of 89 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 87 publications over 28 distinct years, with a maximum of 8 publications in 2016

Contact for Mentoring:

801 Massachusetts Ave Crosstown Center
Boston MA 02118
Google Map

Laing's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department